When GlaxoSmithKline announced a series of initiatives to improve access to drugs in least-developed countries, its most radical proposal was for a “patent pool” to generate research into neglected diseases. Meanwhile, Unitaid was designing its own pool, focused on AIDS research. In Nairobi Xan Rice looks at progress on the two pools and GSK’s other proposals
14 Jul 10 Comments (1)A taste of democracy on the Nile
Amid preparations for Sudan’s controversial election last month, Xan Rice met a Sudanese man from Sydney who was looking well beyond election day
06 May 10 Comments (0)China’s Copenhagen paradox
China’s decision to resist binding emissions targets at Copenhagen gives a glimpse of a country with big and sometimes conflicting plans for growth, trade and influence, writes Peter Browne
14 Jan 10 Comments (0)Big promises from Big Pharma
GlaxoSmithKline created waves last year with a promise of cheaper drugs and patent waivers in developing countries. In this special report Qudsiya Karrim in Johannesburg looks at what the pledge means in practice
09 Jan 10 Comments (0)HIV/AIDS: the global outlook
For World AIDS Day 2009, Dennis Altman surveys the key international issues in prevention and treatment
26 Nov 09 Comments (0)Radicalising Somalia
Five Melbourne men arrested this week were alleged to have links with the radical Somali organisation, al-Shabaab. Peter Browne looks at how international involvement in Somalia in recent years has helped fuel the growth of militancy
06 Aug 09 Comments (0)Zuma unleashed
The less glorious traditions of the ANC have been on vivid display during South Africa’s election campaign, writes Nic Dawes
08 Apr 09 Comments (0)